NCT02171598View on ClinicalTrials.gov

Investigation of the Impact of Concomitant Use of Multiple Doses of Clopidogrel With Multiple Doses of Dabigatran Etexilate on the Pharmacokinetic and Pharmacodynamic Parameters in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

July 31, 2009

Conditions
Healthy
Interventions
DRUG

Clopidogrel

DRUG

Dabigatran high dose

DRUG

Dabigatran low dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02171598 - Investigation of the Impact of Concomitant Use of Multiple Doses of Clopidogrel With Multiple Doses of Dabigatran Etexilate on the Pharmacokinetic and Pharmacodynamic Parameters in Healthy Male Subjects | Biotech Hunter | Biotech Hunter